RSM US 4Q Spotlights: Healthcare growth prospects rosy; IT diversifying
December 11, 2015
Click to get free access to the reports
The second installment of RSM US Quarterly Spotlights is here. Packed with insight from industry professionals, the two latest Healthcare and IT reports break down the primary trends within both spaces, examining M&A activity, private equity investment and more to produce a clear snapshot of current market conditions, as well as what is in store for next quarter.
Key healthcare highlights:
326 M&A deals closed in 3Q, worth a total of $82 billion
Vigorous growth across the sector continues to render it alluring to investors, but complying with increasing regulatory heft remains challenging
Healthcare services is a primary focus, although buyers are still spending plenty of money consolidating in pharma & biotech
Key IT highlights:
Increasing decentralization is likely to only accelerate, with offshore operations more and more common
405 M&A deals for a total of $33 billion closed in 3Q
There's no stopping SaaS—the market penetration of that model is only deepening into specific sector niches
Click here to read all the latest RSM US Quarterly Spotlights, including analysis on the B2B and B2C sectors, for free.